# A Study of JNJ-98768111 in Participants With Advanced Prostate Cancer

> **NCT07746713** · PHASE1 · RECRUITING · sponsor: **Janssen Research & Development, LLC** · enrollment: 100 (estimated)

## Conditions studied

- Prostatic Neoplasms

## Interventions

- **DRUG:** JNJ-98768111

## Key facts

- **NCT ID:** NCT07746713
- **Lead sponsor:** Janssen Research & Development, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-08-05
- **Primary completion:** 2029-03-16
- **Final completion:** 2029-03-16
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07746713

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07746713, "A Study of JNJ-98768111 in Participants With Advanced Prostate Cancer". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07746713. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*